Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
HRV Pharma - Market Expansion Leader in Pharmaceuticals.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - POWDER;INTRAVENOUS - EQ 1.25GM BASE/...DOSAGE - POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 1.5GM BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 1.75GM BASE/...DOSAGE - POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 250MG BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 2GM BASE/VIA...DOSAGE - POWDER;INTRAVENOUS - EQ 2GM BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 750MG BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1.25GM...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1.25GM BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1.5MG ...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1.5MG BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 10GM B...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1GM BA...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 500MG ...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 5GM BA...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 750MG ...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 750MG BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - CAPSULE;ORAL - EQ 125MG BASE
USFDA APPLICATION NUMBER - 50606
DOSAGE - CAPSULE;ORAL - EQ 250MG BASE
USFDA APPLICATION NUMBER - 50606
Related Excipient Companies
Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Empty Capsules
Coating Systems & Additives
Parenteral
Solubilizers
Film Formers & Plasticizers
Thickeners and Stabilizers
Controlled & Modified Release
Granulation
Taste Masking
Lubricants & Glidants
Fillers, Diluents & Binders
Emulsifying Agents
Co-Processed Excipients
Direct Compression
Surfactant & Foaming Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
63
PharmaCompass offers a list of Vancomycin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vancomycin Hydrochloride manufacturer or Vancomycin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vancomycin Hydrochloride manufacturer or Vancomycin Hydrochloride supplier.
A Vancocin HCL In Plastic Container manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vancocin HCL In Plastic Container, including repackagers and relabelers. The FDA regulates Vancocin HCL In Plastic Container manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vancocin HCL In Plastic Container API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vancocin HCL In Plastic Container manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Vancocin HCL In Plastic Container supplier is an individual or a company that provides Vancocin HCL In Plastic Container active pharmaceutical ingredient (API) or Vancocin HCL In Plastic Container finished formulations upon request. The Vancocin HCL In Plastic Container suppliers may include Vancocin HCL In Plastic Container API manufacturers, exporters, distributors and traders.
click here to find a list of Vancocin HCL In Plastic Container suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Vancocin HCL In Plastic Container DMF (Drug Master File) is a document detailing the whole manufacturing process of Vancocin HCL In Plastic Container active pharmaceutical ingredient (API) in detail. Different forms of Vancocin HCL In Plastic Container DMFs exist exist since differing nations have different regulations, such as Vancocin HCL In Plastic Container USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vancocin HCL In Plastic Container DMF submitted to regulatory agencies in the US is known as a USDMF. Vancocin HCL In Plastic Container USDMF includes data on Vancocin HCL In Plastic Container's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vancocin HCL In Plastic Container USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vancocin HCL In Plastic Container suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vancocin HCL In Plastic Container Drug Master File in Japan (Vancocin HCL In Plastic Container JDMF) empowers Vancocin HCL In Plastic Container API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vancocin HCL In Plastic Container JDMF during the approval evaluation for pharmaceutical products. At the time of Vancocin HCL In Plastic Container JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vancocin HCL In Plastic Container suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Vancocin HCL In Plastic Container Drug Master File in Korea (Vancocin HCL In Plastic Container KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Vancocin HCL In Plastic Container. The MFDS reviews the Vancocin HCL In Plastic Container KDMF as part of the drug registration process and uses the information provided in the Vancocin HCL In Plastic Container KDMF to evaluate the safety and efficacy of the drug.
After submitting a Vancocin HCL In Plastic Container KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Vancocin HCL In Plastic Container API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Vancocin HCL In Plastic Container suppliers with KDMF on PharmaCompass.
A Vancocin HCL In Plastic Container CEP of the European Pharmacopoeia monograph is often referred to as a Vancocin HCL In Plastic Container Certificate of Suitability (COS). The purpose of a Vancocin HCL In Plastic Container CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vancocin HCL In Plastic Container EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vancocin HCL In Plastic Container to their clients by showing that a Vancocin HCL In Plastic Container CEP has been issued for it. The manufacturer submits a Vancocin HCL In Plastic Container CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vancocin HCL In Plastic Container CEP holder for the record. Additionally, the data presented in the Vancocin HCL In Plastic Container CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vancocin HCL In Plastic Container DMF.
A Vancocin HCL In Plastic Container CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vancocin HCL In Plastic Container CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vancocin HCL In Plastic Container suppliers with CEP (COS) on PharmaCompass.
A Vancocin HCL In Plastic Container written confirmation (Vancocin HCL In Plastic Container WC) is an official document issued by a regulatory agency to a Vancocin HCL In Plastic Container manufacturer, verifying that the manufacturing facility of a Vancocin HCL In Plastic Container active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vancocin HCL In Plastic Container APIs or Vancocin HCL In Plastic Container finished pharmaceutical products to another nation, regulatory agencies frequently require a Vancocin HCL In Plastic Container WC (written confirmation) as part of the regulatory process.
click here to find a list of Vancocin HCL In Plastic Container suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vancocin HCL In Plastic Container as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vancocin HCL In Plastic Container API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vancocin HCL In Plastic Container as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vancocin HCL In Plastic Container and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vancocin HCL In Plastic Container NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vancocin HCL In Plastic Container suppliers with NDC on PharmaCompass.
Vancocin HCL In Plastic Container Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vancocin HCL In Plastic Container GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vancocin HCL In Plastic Container GMP manufacturer or Vancocin HCL In Plastic Container GMP API supplier for your needs.
A Vancocin HCL In Plastic Container CoA (Certificate of Analysis) is a formal document that attests to Vancocin HCL In Plastic Container's compliance with Vancocin HCL In Plastic Container specifications and serves as a tool for batch-level quality control.
Vancocin HCL In Plastic Container CoA mostly includes findings from lab analyses of a specific batch. For each Vancocin HCL In Plastic Container CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vancocin HCL In Plastic Container may be tested according to a variety of international standards, such as European Pharmacopoeia (Vancocin HCL In Plastic Container EP), Vancocin HCL In Plastic Container JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vancocin HCL In Plastic Container USP).
